CASE STUDY |
|
Year : 2014 | Volume
: 41
| Issue : 1 | Page : 34-36 |
|
Massive pulmonary embolism in rheumatoid patient treated with raloxifene: a case report
Hala M Haider
Physical Medicine, Rehabilitation and Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Correspondence Address:
Hala M Haider Physical Medicine, Rehabilitation and Rheumatology Department, Faculty of Medicine, Ain Shams University Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/1110-161X.128134
|
|
Introduction
Rheumatoid arthritis (RA) is not generally considered a risk factor for venous thromboembolism.
Case presentation
A patient with RA and postmenopausal osteoporosis was reported with massive pulmonary embolism following treatment with raloxifene for 3 months. This patient met the American College of Rheumatology (ACR) criteria for RA diagnosis in 1988. She was controlled on regular disease modifying antirheumatic drug (DMARDs) for 4 years.
Conclusion
Pulmonary embolism in postmenopausal osteoporotic patient with RA could be due to raloxifene treatment rather than a complication of the disease itself. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|